Customized End-to-End Solutions to Explore the Microbiome in Preclinical Research
The microbiome represents a novel and exciting therapeutic target, with a critical function in the maintenance of immune homeostasis, and a dysfunctional microbiome is linked to a diverse range of disease states.
Historically, microbiome research has been hampered by requirements for unique expertise, facilities, and animals. The costs and logistics involved have proven significant barriers to entry for investigators who want to explore the microbiome's impact on disease etiology, progression, and treatment, as well as its potential as a therapeutic.
The Taconic-Biomodels Microbiome Initiative (TBMI) provides researchers with seamless access to complete germ-free microbiome study solutions, from design to data. This unique initiative turns microbiome study ideas into actionable plans without researchers having to invest in their own germ-free/gnotobiotic vivarium.
In this webinar, you will hear from Dr. Caitlin SL Parello, Associate Director of Research Operations at Biomodels as she explores the microbiome's significant role in human health and disease, and how TBMI can support your research.
- Get an overview of major areas of preclinical microbiome research and common questions
- Get insight into Biomodels' and Taconic's joint approach to novel microbiome strategies in preclinical animal modeling
- Learn about examples of microbiome-focused research concepts, study designs, and outcomes
Start Your Next Microbiome Research Project!
Schedule a scientific consultation to learn how this unique Taconic-Biomodels Microbiome Initiative can help you achieve your research goals.
Caitlin SL Parello, PhD
Associate Director of Research Operations | Biomodels
Dr. Parello joined Biomodels in 2016 as an Associate Scientist after completing her post-doctoral studies in the Department of Pathology at the University of Massachusetts Medical School where she focused on the development of a clinically relevant, humanized murine model of Experimental Autoimmune Encephalomyelitis (EAE) as a conduit for assessing interventions for multiple sclerosis (MS). Caitlin received her PhD from Boston University School of Medicine in 2014, where she adapted two murine models of Shiga Toxin 2- induced kidney injury, and was an NIH- funded pre-doctoral fellow and Russek award winner.
At Biomodels, Caitlin has successfully combined her background in adaptive immunity and murine model development, and has incorporated both into assisting clients in addressing questions around product development in areas that include the interaction of the microbiome and immune system, the potential dysbiosis mediating inflammatory/autoimmune disorders, and determining if restoration of eubiosis can be therapeutic for such disorders. Dr. Parello led the establishment of our germ-free/gnotobiotic murine isolator facility, and serves as the lead scientist on microbiome-related studies.